Identification of a Prognostic Microenvironment-Related Gene Signature in Glioblastoma Patients Treated with Carmustine Wafers

SIMPLE SUMMARY: Carmustine wafer (CW) implantation into the resection cavity of patients operated for glioblastoma (GBM) was approved as an adjuvant treatment before the Stupp Protocol. Although contrasting clinical results limited its use, our retrospective study on 116 GBM treated with CW showed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Manini, Ivana, Dalla, Emiliano, Vendramin, Vera, Cesselli, Daniela, Di Loreto, Carla, Skrap, Miran, Ius, Tamara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320240/
https://www.ncbi.nlm.nih.gov/pubmed/35884475
http://dx.doi.org/10.3390/cancers14143413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320240/
https://www.ncbi.nlm.nih.gov/pubmed/35884475
http://dx.doi.org/10.3390/cancers14143413

Ejemplares similares